This is a must read. If you cannot see this email properly, please click [here](
To unsubscribe from this mailing list please click [here]( Below is an important message from one of our highly valued sponsors. Please read it carefully as they have some special information to share with you. --------------------------------------------------------------- [AI Discovers Breakthrough New Cancer Treatment?](
Dear Reader, Just recently, scientists in Canada were able to use AI to create a new cancer treatment in less than 30 days! Now, cancer alone is a significant market worth hundreds of billions of dollars annually… Just think about the implications if AI were to find a cure and take over this market. Now take a moment to picture what might happen if AI were to cure other diseases like Alzheimer’s… heart disease… and more – as I fully expect it will… [It could be worth trillions of dollars of economic impact – and keep in mind we’re still only talking about one industry.]( Multiply this impact over every industry, and you’re looking at a breakthrough worth tens, possibly even hundreds of trillions of dollars. That’s why I’m so excited about AI and why, as one prominent world leader puts it, “whoever controls AI will become the ruler of the world.” Because of that, any early investor who acts today – while this technology is still in its infancy – could see the chance at making a potential huge fortune over time. [Click here now to see the 3 tiny AI stocks we believe are best positioned to profit.]( Regards, Matt Insley
Publisher, Paradigm Press --------------------------------------------------------------- This ad is sent on behalf of Paradigm Press, LLC, at 808 St. Paul Street, Baltimore MD 21202. If you're not interested in this opportunity from Paradigm Press, LLC, please click [here]( to remove your email from these offers. MarketMoversPress.com Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be third-party advertisements where the advertiser is paying per click, per lead, or per sale and are not endorsed or warranted by our staff or company. SPMG, MarketMoversPress.com and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged not to use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. SPMG, MarketMoversPress.com nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from SPMG or MarketMoversPress.com to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. [By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer.](
